#VisualAbstract Pembrolizumab after CD19-directed CAR T-cell therapy appears safe and may achieve clinical responses in patients with relapsed/refractory B-cell lymphomas

byKathleen Lau

September 16, 2021

in StudyGraphics

Detection of pathogenic genetic variants in early-onset atrial fibrillation

RelatedReports

Vegetarian diet may lower incidence of colorectal cancer

Lifestyle

Plant-based diets may be associated with lower risk of aggressive prostate cancer

January 27, 2023

StudyGraphics

#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer

January 24, 2023

Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs

Chronic Disease

Early-life body size not an independent risk factor for colorectal cancer

January 11, 2023

No benefit of erlotinib in combined hepatocellular carcinoma treatment

Oncology

Spiritual care reduces fatigue and pain among patients receiving chemotherapy

January 11, 2023

Hybrid minimally invasive esophagectomy associated with lower complication rates compared to open esophagectomy

Camrelizumab with chemotherapy demonstrated improved overall survival and progression-free survival of esophageal squamous cell carcinoma patients versus placebo

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

Mental health in young adults may be linked to sleep chronotype

#Visual Abstract Watchful waiting may be an appropriate strategy for some patients with basal cell carcinomas

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract Pembrolizumab after CD19-directed CAR T-cell therapy appears safe and may achieve clinical responses in patients with relapsed/refractory B-cell lymphomas

Plant-based diets may be associated with lower risk of aggressive prostate cancer

#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer

Early-life body size not an independent risk factor for colorectal cancer

Detection of pathogenic genetic variants in early-onset atrial fibrillation

Camrelizumab with chemotherapy demonstrated improved overall survival and progression-free survival of esophageal squamous cell carcinoma patients versus placebo

RelatedReports

Plant-based diets may be associated with lower risk of aggressive prostate cancer

#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer

Early-life body size not an independent risk factor for colorectal cancer

Spiritual care reduces fatigue and pain among patients receiving chemotherapy

Camrelizumab with chemotherapy demonstrated improved overall survival and progression-free survival of esophageal squamous cell carcinoma patients versus placebo

Mental health in young adults may be linked to sleep chronotype

#Visual Abstract Watchful waiting may be an appropriate strategy for some patients with basal cell carcinomas

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written
medical news?

#VisualAbstract Pembrolizumab after CD19-directed CAR T-cell therapy appears safe and may achieve clinical responses in patients with relapsed/refractory B-cell lymphomas

RELATED REPORTS

Detection of pathogenic genetic variants in early-onset atrial fibrillation

Camrelizumab with chemotherapy demonstrated improved overall survival and progression-free survival of esophageal squamous cell carcinoma patients versus placebo

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written medical news?

Want more physician-written
medical news?